3-47848237-C-T
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_138615.3(DHX30):c.2344C>T(p.Arg782Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R782Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_138615.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DHX30 | NM_138615.3 | c.2344C>T | p.Arg782Trp | missense_variant | 15/22 | ENST00000445061.6 | NP_619520.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DHX30 | ENST00000445061.6 | c.2344C>T | p.Arg782Trp | missense_variant | 15/22 | 1 | NM_138615.3 | ENSP00000405620.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with severe motor impairment and absent language Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Oct 02, 2021 | Same nucleotide change resulting in same amino acid change has been previously reported as de novoo and observed in at least four similarly affected unrelated individuals (3billion dataset, ClinVar ID: VCV000375373.4, PMID: 29100085 and 28327206, PS2 and PS4). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). Missense changes are a common disease-causing mechanism (PP2). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: :0.959, 3Cnet: 0.889, PP3). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 27, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 31, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jun 11, 2020 | Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan (exon 15). (N) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (P) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants, (helicase nucleic acid-binding motif VI; PMID: 29100085).(P) 0801 - Strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic and de novo in multiple patients with a neurodevelopmental disorder (ClinVar, PMID: 28327206, PMID: 29100085). (P) 1002 - Moderate functional evidence supporting abnormal protein function. Transfected HEK293 cells demonstrate that this mutation results in significantly reduced ATPase activity and protein translation (PMID: 29100085). (P) 1203 - Variant shown to be de novo in proband (parental status confirmed). (P) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 23, 2023 | Published functional studies demonstrate R782W impaired ATPase activity as well as increased the propensity of stress granule formation which lead to a global decrease in protein synthesis (Lessel et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28327206, 29100085, 31216405, 34020708) - |
Hirsutism;C0151611:EEG abnormality;C0349588:Short stature;C0557874:Global developmental delay;C1858120:Generalized hypotonia;C2315100:Failure to thrive;C3714756:Intellectual disability;C4551563:Microcephaly Pathogenic:1
Pathogenic, no assertion criteria provided | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | - | This variant was identified as de novo in 2 unrelated individuals with intellectual disability, microcephaly, and short stature. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at